Location History:
- Holon, IL (1976)
- Cholon, IL (1978 - 1980)
- Rehovot, IL (1992 - 2018)
Company Filing History:
32 out of 1,168 
3 out of 65 
1 out of 810 
Years Active: 1976-2018
Title: Matityahu Fridkin: Inventor Extraordinaire
Introduction:
Get ready to discover the brilliant mind behind a multitude of groundbreaking inventions and patents. Meet Matityahu Fridkin, hailing from Rehovot, Israel, and a remarkable figure in the field of pharmaceutical research and drug development. With an impressive portfolio of 34 patents, Fridkin has made significant contributions to the medical community, particularly in the treatment of diseases such as schizophrenia and Alzheimer's. Join us as we delve into his latest patents, career highlights, and notable collaborations.
Latest Patents:
Fridkin has continued to push the boundaries of medical science with his latest patents. One of his notable inventions is the development of Modified Kisspeptin Peptides for the treatment of various diseases and disorders associated with cognitive impairment, sensory gating function impairment, depression, and behavioral abnormalities. These synthetic modified peptides, comprising five to seven natural or non-natural amino acids, show tremendous potential in addressing conditions like schizophrenia and Alzheimer's disease. Their therapeutic potential lies in their ability to regulate and modulate key physiological processes.
Another groundbreaking invention by Fridkin is the creation of Reversible Pegylated Drugs. By derivatizing drug compounds with groups sensitive to mild basic conditions, such as Fmoc or FMS, he has devised a method that allows attachment of PEG moieties to the drug. Unlike traditional approaches, where the PEG moiety and the drug residue are directly linked, Fridkin's invention employs a more flexible and reversible linkage. This innovation opens up new possibilities for drug delivery and makes it easier to adjust dosage and effect duration.
Career Highlights:
Throughout his career, Matityahu Fridkin has worked with esteemed organizations in the field of research and development. Notably, he has been associated with Yeda Research and Development Co Ltd, renowned for its contributions in commercializing discoveries made at the Weizmann Institute of Science. Fridkin's collaboration with Yeda underscores his dedication to translating scientific breakthroughs into practical applications that benefit society.
Fridkin has also contributed to the advancement of research through his association with Ramot University Authority for Applied Research and Industrial Development. This organization plays a crucial role in promoting entrepreneurship and technology transfer from Bar-Ilan University, significantly impacting Israel's technological progress.
Collaborations:
Innovation thrives in collaboration, and Fridkin's journey has seen fruitful partnerships with fellow experts. Two notable collaborators include Yoram Shechter and Haim Tsubery. These creative minds have joined forces with Fridkin, combining their unique expertise to develop groundbreaking solutions in the pharmaceutical industry. Together, they have furthered the boundaries of drug development, ensuring their collective efforts leave lasting impacts on the medical field.
Conclusion:
Matityahu Fridkin's exceptional contributions to the field of pharmaceuticals and drug development have left an indelible mark on medical science. With an impressive repertoire of 34 patents, Fridkin's groundbreaking inventions cater to pressing medical needs, including the treatment of cognitive impairments, sensory gating function impairment, and mental disorders like schizophrenia and Alzheimer's disease. Collaborating with esteemed organizations like Yeda Research and Development Co Ltd and Ramot University Authority, Fridkin's commitment to innovation and scientific advancement remains unwavering. As we eagerly await his future endeavors, there is no doubt that Matityahu Fridkin's contributions will continue to revolutionize the world of medicine.